CenterBook Partners LP increased its position in Molina Healthcare, Inc (NYSE:MOH – Free Report) by 15.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 23,648 shares of the company’s stock after buying an additional 3,239 shares during the quarter. CenterBook Partners LP’s holdings in Molina Healthcare were worth $4,104,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds also recently made changes to their positions in MOH. AQR Capital Management LLC increased its stake in shares of Molina Healthcare by 217.0% in the third quarter. AQR Capital Management LLC now owns 2,934,130 shares of the company’s stock worth $561,475,000 after buying an additional 2,008,458 shares during the period. Victory Capital Management Inc. increased its stake in shares of Molina Healthcare by 344.3% in the third quarter. Victory Capital Management Inc. now owns 963,526 shares of the company’s stock worth $184,380,000 after buying an additional 746,639 shares during the period. Norges Bank purchased a new position in shares of Molina Healthcare in the fourth quarter worth $109,766,000. UBS Group AG increased its stake in shares of Molina Healthcare by 320.7% in the third quarter. UBS Group AG now owns 603,934 shares of the company’s stock worth $115,569,000 after buying an additional 460,372 shares during the period. Finally, Viking Global Investors LP purchased a new position in shares of Molina Healthcare in the second quarter worth $79,665,000. 98.50% of the stock is owned by hedge funds and other institutional investors.
Molina Healthcare Stock Performance
Shares of Molina Healthcare stock opened at $198.34 on Tuesday. The stock has a market cap of $10.33 billion, a price-to-earnings ratio of 58.68 and a beta of 0.80. The firm’s 50-day moving average is $169.59 and its 200 day moving average is $162.97. Molina Healthcare, Inc has a 1 year low of $121.06 and a 1 year high of $311.52. The company has a debt-to-equity ratio of 0.97, a current ratio of 1.63 and a quick ratio of 1.63.
Analyst Upgrades and Downgrades
A number of brokerages have issued reports on MOH. Barclays boosted their price objective on shares of Molina Healthcare from $161.00 to $199.00 and gave the company an “underweight” rating in a research report on Tuesday, May 26th. Sanford C. Bernstein reissued an “outperform” rating on shares of Molina Healthcare in a research report on Friday, March 13th. JPMorgan Chase & Co. boosted their price objective on shares of Molina Healthcare from $169.00 to $191.00 and gave the company a “neutral” rating in a research report on Monday. Zacks Research raised shares of Molina Healthcare from a “strong sell” rating to a “hold” rating in a research report on Monday, April 20th. Finally, Truist Financial boosted their price objective on shares of Molina Healthcare from $180.00 to $205.00 and gave the company a “hold” rating in a research report on Monday, May 11th. Three investment analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat, Molina Healthcare has an average rating of “Hold” and a consensus target price of $182.73.
Check Out Our Latest Stock Analysis on Molina Healthcare
Insider Transactions at Molina Healthcare
In related news, CAO Maurice Hebert sold 600 shares of the company’s stock in a transaction dated Thursday, May 14th. The shares were sold at an average price of $191.55, for a total value of $114,930.00. Following the transaction, the chief accounting officer owned 12,815 shares in the company, valued at $2,454,713.25. The trade was a 4.47% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Jeff D. Barlow sold 17,811 shares of the company’s stock in a transaction dated Monday, May 11th. The shares were sold at an average price of $186.12, for a total transaction of $3,314,983.32. Following the transaction, the insider owned 67,175 shares in the company, valued at $12,502,611. This represents a 20.96% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders own 1.44% of the company’s stock.
Molina Healthcare Company Profile
Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.
The company traces its roots to the early 1980s, when Dr.
Read More
- Five stocks we like better than Molina Healthcare
- 3 Stocks With Fresh Catalysts to Watch Before the July 4
- Amprius Insiders Are Selling: Should Investors Be Worried?
- A Weaker Dollar Could Put These 3 Industrial Stocks Back in Focus
- A Market Rotation Toward Quality Will Benefit These 3 ETFs
Want to see what other hedge funds are holding MOH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Molina Healthcare, Inc (NYSE:MOH – Free Report).
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
